慢性肾小球肾炎蛋白尿中医药治疗进展

通过对近几年中医对肾小球肾炎蛋白尿辨证及疗效的总结,以达到开拓思路,提高辨证的准确性和疗效的确切性。     

中医药治疗慢性肾炎蛋白尿近况

综合分析近几年来中医药治疗慢性肾炎蛋白尿的临床研究近况。对病因病机的认识更加完善，运用中草药、针灸、穴位注射等方法在临床治疗中取得了满意疗效。     

慢性肾炎蛋白尿的中医药治疗进展

慢性肾炎是临床最为常见的肾脏疾病,也是我国导致慢性肾衰竭的首位病因。其病程是渐进发展的,慢性肾衰竭是该病的最终结局,而一旦进入终末期肾衰竭,替代治疗的巨额费用将给患者和社会带来沉重的负担。慢性肾炎起始因素多为免疫介导炎症,导致病程慢性化的机制除免疫因素外,非免疫和非炎症因素也占有重要作用,其中尿蛋白是。肾脏病理损害持续进展的重要原因之一,     

糖尿病肾病蛋白尿中医药治疗

糖尿病肾病中医学统一命名为“消渴病肾病”,在总结临床实践基础上发现消渴病肾病以肾络瘀痹为病机核心,并贯穿于消渴病肾病的始终.而肾元虚损,与湿、热、毒、痰、瘀互结,形成肾络瘀痹的不同特点.早期以阴虚燥热、气阴两虚为主,逐步出现气阴两虚、气虚偏重,或脾肾气虚,甚至出现气虚涉及阳虚之证.消渴病肾病蛋白尿是肾气虚损害的标志,患者蛋白尿量越大,脾肾气虚越明显,随着蛋白尿量越大,水肿显现,脾肾阳虚病机转换越显著.消渴病肾病病机复杂,变证丛生;治疗重在通络保肾;利水消肿注重提壶揭盖、活血利水;病情稳定也需调理脾胃、清理胃肠.形成通络保肾复方系列经验方,中医临床疗效确切.     

赵刚教授中医药治疗肾性蛋白尿经验

赵师认为,肾性蛋白尿病位主要在肾,常以虚中夹实、虚实夹杂为多见。治疗中注重遵循辨证施治、辨证与辨病相结合的原则,尤为强调以脾肾为本,注重整体,分清疾病过程中的主要和次要矛盾,提倡中西医综合治疗。同时注重预防调护。     

蛋白尿的中医辨证治疗

阐述蛋白尿的中医病因病机,分型论治（脾肾气虚型、气阴两虚型、肾阴不足型）,及中药的现代药理研究对临床治疗的裨益。     

蛋白尿加速慢性肾脏病进展的分子机制

慢性肾脏病常伴有肾小球滤过屏障结构和/或功能的障碍,导致蛋白尿,近二十年来研究发现蛋白尿不仅仅是慢性肾脏病的重要表现,而且还是其进展至终末期肾病的一个独立危险因素.     

蛋白尿的中医辨证治疗

阐述蛋白尿的中医病因病机,分型论治(脾肾气虚型、气阴两虚型、肾阴不足型),及中药的现代药理研究对临床治疗的裨益。     

肾性蛋白尿的中医药治疗

蛋白尿是肾脏疾病的重要表现,也是导致肾功损害的主要因素之一。而中医药对减轻肾性蛋白尿具有很好疗效。文章认为蛋白尿的病因病机,以脾肾亏虚为本,风邪、湿热、瘀血为标,临床应对其详辨,分清主次,进行辨证论治。     

论现代慢性病的特点及其中医诊治策略

随着经济、科技、人文的发展,现代慢性病也具有鲜明的时代特征。现代中医的治疗要充分把握其时代特点,采取与时代相适应的辨证观念和诊治策略,最大程度满足临床需求。     

肾性蛋白尿的中医治疗

蛋白尿是肾脏疾病最常见的临床症状之一,大量蛋白尿会引起肾小球基底膜增厚、系膜基质增加而致肾小球硬化,最终出现肾功能衰竭。临床表现多种多样如:水肿、血尿、高血压、肾功能损害等,多属于中医的尿浊、腰痛、水肿、尿血、眩晕、虚劳等病症的范畴。中医予以益气健脾,补肾固涩,疏肝理气,辛凉解表,辛温解表,清热利湿,活血化瘀治疗。     

Chinese Medicine in Management of Chronic Disease Endometriosis

Endometriosis (EM), a refractory, highly recurrent and life-threatening chronic disease, requires long-term management and long-term drug treatment. Our previous studies showed that Chinese medicine (CM) can inhibit the postoperative recurrence of EM, improve quality of life, shorten the time to conception and increase pregnancy rates. CM produces few adverse reactions with high safety. These characteristics might be associated with the mechanism of CM''s inhibition of recurrence. Therefore, we believe that CM may represent a good choice for long-term drug treatment and is worthy of clinical application.     

Colon May Provide New Therapeutic Targets for Treatment of Chronic Kidney Disease with Chinese Medicine

Chronic kidney disease(CKD) has become a worldwide health and social problem.Retarding its progression to end-stage renal disease is beneficial both to the patients and the healthcare system.Plenty of clinical trials have indicated that enema with Chinese medicine could effectively prevent chronic renal failure,and was widely used in the clinical practice.However,studies on mechanism were still nearly blank,which may prevent further improvement of therapeutic efficacy.Recent studies had discovered that colon was an important organ where uremic toxins were generated.The uremic toxins involved could not only promote CKD progression,but also was closely correlated with CKD mortality.Reducing production and promoting excretion of toxins were confirmed to reduce renal tubule interstitial fibrosis and delay renal progression.On the basis of the theory of gut-kidney axis above,we had conducted pilot clinical researches to evaluate the effect of enema with Chinese medicine on the intestinal flora,gut barrier,enterogenous uremic toxins and renal protection.The preliminary results revealed that rheum enema through colon could accelerate intestinal dynamics,improve intestinal barrier function,regulate intestinal flora and reduce production and absorption of intestine-derived uremic toxins such as indoxyl sulfate,which may reduce renal fibrosis and delay renal progression.Further studies could provide more evidence for colon as a new therapeutic target for the treatment of CKD with Chinese medicine.     

New Goals and Strategies of Chinese Medicine in Prevention and Treatment of Chronic Kidney Disease

Chronic kidney disease (CKD) is a clinical syndrome with a series of clinical manifestations and metabolic disorders caused by many diseases, which are characterized by progressive deterioration or irreversible damage of renal structures and functions. With the progress of epidemiological research, CKD has brought about huge economic and psychological burdens. There is a considerable risk of cardiovascular events or death than progression to end-stage renal disease for patients. Particular attentions should be paid to the new goals of reducing cardiovascular events and all-cause mortality. It is important to analyze the etiology and pathogenesis according to patients'' ages, regions, primary disease as well as different stages of disease, and choose the appropriate therapeutic strategies accordingly. In clinical practice, due to the uncertainty of therapeutic effects of modern medicine based on the risk factors, it is necessary to use Chinese medicine (CM) to delay the disease progression and reduce comorbidities. Turbid toxin and blood stasis are two critical pathological factors worthy of concerns in the theory of CM. In addition, appropriate use of CM may help improve the quality of life of patients with CKD.     

治疗肾病常用中药的肝毒性及其防治

慢性肾脏病是临床难治性进展性疾病之一,为各种慢性肾实质疾病的基础上缓慢出现肾功能减退而至衰竭的一种病症。中医药在治疗慢性肾脏病方面有着广泛的应用,具有独特的临床优势,但在长期的临床应用中,中医中药的临床应用安全性也越来越受到重视。文章列举了肾科常用中药,从其功效、药理及肝毒性等方面作出简要的介绍,为临床合理用药提供参考。     

中医外治法配合中医药治疗儿童哮喘缓解期研究进展

综合分析近10年来有关小儿哮喘的中医外治法的研究文献,发现中医外治法在小儿哮喘缓解期调理脏腑整体功能等方面积累了丰富的经验,取得了较大的成绩。应充分发挥中医优势,为治疗小儿哮喘提供更好的治疗方法。     

中医药治疗糖尿病足研究进展

糖尿病足是糖尿病常见的严重并发症之一,其高发病率与致残率已成为一个重要的公共卫生问题。中医治疗本病,从整体调节入手,立足于辨证论治,主张分型、分期施治,亦有专方专药,重视内外结合、整体与局部结合、中西医结合、防治结合的综合治疗原则,标本兼顾,虚实并举,用药灵活,疗效显著,在极大程度上提高了糖尿病足的治愈率及有效率,降低了致残率。故综述糖尿病足病因病机、内外治疗方法等中医药治疗研究进展。     

中医药治疗慢性萎缩性胃炎研究进展

慢性萎缩性胃炎在我国发病率很高,且其发病率呈逐年上升趋势;其次CAG的演变规律为“正常胃黏膜-炎症-萎缩-肠化-异型增生-胃癌”已被大家所公认,因此慢性萎缩性胃炎越来越受到人们的重视。现代医学治疗该病尚无特效药,祖国医学结合患者症状辨汪施治,取得良好成效。文章通过论述近年来关于慢性萎缩性胃炎的中医药治疗概况及研究进展,从而为今后临床治疗提供较好的指导。